South-East Asia (WHO region) vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)

South-East Asia (WHO region)
94.0%
in 2024
Togo
100.0%
in 2024
South-East Asia (WHO region) rank
4th
Togo rank
1st

HIV-positive TB patients on ART (antiretroviral therapy) over time

  • South-East Asia (WHO region)
  • Togo
020406080100200320132024

How they compare

Togo currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.

That makes Togo's figure about 1.1 times South-East Asia (WHO region)'s.

The two have swapped places 3 times across 17 shared years of data; in 2008 it was South-East Asia (WHO region) ahead.

South-East Asia (WHO region) ranks 4th and Togo ranks 1st of 11 groups.

Across the 3 decades both report, South-East Asia (WHO region) averaged higher in 1 and Togo in 2.

Head to head by decade

Decade South-East Asia (WHO region) Togo Difference Ahead
2000s 45.5% 33.0% 12.5% South-East Asia (WHO region)
2010s 76.0% 85.1% 9.1% Togo
2020s 92.2% 99.2% 7.0% Togo

Averages of every year both report within each decade.

Frequently asked questions

Which has higher hiv-positive tb patients on art (antiretroviral therapy), South-East Asia (WHO region) or Togo?
Togo, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between South-East Asia (WHO region) and Togo?
6.0%, with Togo ahead.
How many years of comparable data are there for South-East Asia (WHO region) and Togo?
17 years are reported by both, from 2008 to 2024.
How do South-East Asia (WHO region) and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
South-East Asia (WHO region) ranks 4th and Togo ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South-East Asia (WHO region) vs Togo: HIV-positive TB patients on ART (antiretroviral therapy). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 18 September 2026, from https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/south-east-asia-who-region/togo/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/hiv-positive-tb-patients-on-art-antiretroviral-therapy-percent/south-east-asia-who-region/togo/">South-East Asia (WHO region) vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)</a> — Statizoid

About this data

Indicator
HIV-positive TB patients on ART (antiretroviral therapy) (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 2,569 data points, 2003–2024
Last refreshed